Calidi
CLDI
Calidi (CLDI) news
Recent news
Calidi: reverse stock split, expected to begin trading on a 1-for-16 split adjusted basis on July 31, 2026
AInvest Wire · Jul 20, 2026Calidi Biotherapeutics appoints former Genentech/Roche and Celgene executive Corsee Sanders, Ph.D., to board of directors
AInvest Wire · Jun 23, 2026Calidi Biotherapeutics - targets CLD-401 regulatory submission by year-end, first-in-human trial in early 2027
AInvest Wire · Jun 16, 2026Calidi Biotherapeutics receives positive pre-IND feedback from US FDA for CLD-401 indicating agreement on its current development strategy as it advances towards a first-in-human study
AInvest Wire · Jun 16, 2026ImportantCalidi Biotherapeutics shares plummet 46% in trading debut
AInvest Wire · Sep 13, 2023Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.